A Phase II Trial of LM103 in Advanced Melanoma

NCT07310784 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

92

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Melanoma

Interventions

BIOLOGICAL: LM103 TILs Injection
DRUG: Dacarbazine, temozolomide, paclitaxel, carboplatin/cisplatin

Sponsor

Suzhou BlueHorse Therapeutics Co., Ltd.